ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Genetic Biomarkers"

  • Abstract Number: 1202 • 2013 ACR/ARHP Annual Meeting

    Two Family Kindreds With Blau’s Syndrome Associated With Unusual NOD2 Mutations

    Qingping Yao, Rheumatic and Immunologic Dis, Cleveland Clinic, Cleveland, OH

    Background/Purpose: The aim of this study was to report families of Blau’s syndrome with unusual NOD2 gene variants. Methods: Two proband patients were seen, and their clinical…
  • Abstract Number: 1201 • 2013 ACR/ARHP Annual Meeting

    A Progress Report On An Emerging Disease: NOD2-Associated Autoinflammatory Disease

    Qingping Yao, Rheumatic and Immunologic Dis, Cleveland Clinic, Cleveland, OH

    Background/Purpose: We recently reported a new disease designated as NOD2-associated autoinflammatory disease (NAID). The aim of this study was to update the progress on defining the disease. Methods: A…
  • Abstract Number: 1211 • 2013 ACR/ARHP Annual Meeting

    Adult Autoinflammatory Phenotypes Associated With Heterozygous MEFV Mutations: A Continuum of Familial Mediterranean Fever?

    Qingping Yao, Rheumatic and Immunologic Dis, Cleveland Clinic, Cleveland, OH

    Background/Purpose: Familial Mediterranean fever (FMF) is traditionally regarded as an autosomal recessive disease characterized by periodic fever, serositis, erysipelas-like erythema and good response to colchicine. The…
  • Abstract Number: 687 • 2013 ACR/ARHP Annual Meeting

    Role Of Class II Human Leukocyte Antigens In The Progression From Early To Definite Systemic Sclerosis

    Barbara Vigone1, Alessandro Santaniello2, Maurizio Marchini1, Gaia Montanelli1, Monica Caronni1, Adriana Severino1, Stefania Celeste1 and Lorenzo Beretta3, 1Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy, 2Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy, 3Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy

    Background/Purpose:  Criteria for the diagnosis of Early Systemic Sclerosis (EaSSc) have been formalized by LeRoy and Medsger in 2001 and later validated by Koenig et…
  • Abstract Number: 170 • 2013 ACR/ARHP Annual Meeting

    Association Of BMI, 8 SNPs Reported To Be Related To Gout Phenotype and Their Interaction In Gout Incidence In Framingham Heart Study

    Jasvinder A. Singh1,2, Ana Vazquez3, Richard Reynolds3, Vinodh Srinivasasainagendra4, S. Louis Bridges Jr.5 and David Allison3, 1Rheumatology, Birmingham VA, Birmingham, AL, 2Department of Medicine, University of Alabama, Tuscaloosa, AL, 3University of Alabama at Birmingham, Birmingham, AL, 4University of alabama at birmingham, birmingham, AL, 5Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: We aim to assess the association of 8 serum urate SNPs and BMI and their interactions with incident gout in a population-based cohort study. Methods:…
  • Abstract Number: 173 • 2013 ACR/ARHP Annual Meeting

    HLA-DRB1*08:02 Is Associated With Bucillamine-Induced Proteinuria In Japanese Rheumatoid Arthritis Patients: A Case-Control Study

    Hiroshi Furukawa1, Shomi Oka1, Kota Shimada2, Shoji Sugii2, Atsushi Hashimoto3, Akiko Komiya1, Naoshi Fukui1, Taiichiro Miyashita4, Kiyoshi Migita4, Akiko Suda5, Shouhei Nagaoka6, Naoyuki Tsuchiya7 and Shigeto Tohma1, 1Clinical Research Center for Allergy and Rheumatology, Sagamihara Hospital, National Hospital Organization, Sagamihara, Japan, 2Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan, 3Department of Rheumatology, Sagamihara Hospital, National Hospital Organization, Sagamihara, Japan, 4Clinical Research Center, Nagasaki Medical Center, National Hospital Organization, Omura, Japan, 5Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Japan, 6Department of Rheumatology, Yokohama Minami Kyousai Hospital, Yokohama, Japan, 7Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

    Background/Purpose: Bucillamine (Buc) is one of the commonly used disease-modifying anti-rheumatic drugs (DMARDs) in Japan. Drug-induced proteinuria can occur in rheumatoid arthritis (RA) patients treated…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology